nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—systemic scleroderma	0.613	1	CpDpCtD
Almotriptan—CYP2C8—Mometasone—systemic scleroderma	0.073	0.303	CbGbCtD
Almotriptan—CYP1A2—Pentoxifylline—systemic scleroderma	0.0382	0.158	CbGbCtD
Almotriptan—CYP1A2—Leflunomide—systemic scleroderma	0.0364	0.151	CbGbCtD
Almotriptan—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0291	0.121	CbGbCtD
Almotriptan—CYP2D6—Captopril—systemic scleroderma	0.0235	0.0977	CbGbCtD
Almotriptan—CYP2C19—Prednisone—systemic scleroderma	0.0195	0.0809	CbGbCtD
Almotriptan—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0118	0.0489	CbGbCtD
Almotriptan—CYP3A4—Prednisone—systemic scleroderma	0.00942	0.0391	CbGbCtD
Almotriptan—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00122	CcSEcCtD
Almotriptan—Dyspnoea—Leflunomide—systemic scleroderma	0.000178	0.00122	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000178	0.00122	CcSEcCtD
Almotriptan—Discomfort—Lisinopril—systemic scleroderma	0.000177	0.00121	CcSEcCtD
Almotriptan—Dyspepsia—Leflunomide—systemic scleroderma	0.000176	0.0012	CcSEcCtD
Almotriptan—Vomiting—Mometasone—systemic scleroderma	0.000176	0.0012	CcSEcCtD
Almotriptan—Dry mouth—Lisinopril—systemic scleroderma	0.000175	0.0012	CcSEcCtD
Almotriptan—Sweating increased—Prednisone—systemic scleroderma	0.000175	0.00119	CcSEcCtD
Almotriptan—Feeling abnormal—Azathioprine—systemic scleroderma	0.000174	0.00119	CcSEcCtD
Almotriptan—Rash—Mometasone—systemic scleroderma	0.000174	0.00119	CcSEcCtD
Almotriptan—Asthenia—Captopril—systemic scleroderma	0.000174	0.00119	CcSEcCtD
Almotriptan—Dermatitis—Mometasone—systemic scleroderma	0.000174	0.00119	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000174	0.00119	CcSEcCtD
Almotriptan—Confusional state—Lisinopril—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Headache—Mometasone—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Insomnia—Mycophenolic acid—systemic scleroderma	0.000173	0.00118	CcSEcCtD
Almotriptan—Fatigue—Leflunomide—systemic scleroderma	0.000172	0.00118	CcSEcCtD
Almotriptan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000172	0.00117	CcSEcCtD
Almotriptan—Pruritus—Captopril—systemic scleroderma	0.000172	0.00117	CcSEcCtD
Almotriptan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000171	0.00117	CcSEcCtD
Almotriptan—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00117	CcSEcCtD
Almotriptan—Pain—Leflunomide—systemic scleroderma	0.000171	0.00117	CcSEcCtD
Almotriptan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00017	0.00116	CcSEcCtD
Almotriptan—Somnolence—Mycophenolic acid—systemic scleroderma	0.00017	0.00116	CcSEcCtD
Almotriptan—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00116	CcSEcCtD
Almotriptan—Shock—Lisinopril—systemic scleroderma	0.000169	0.00115	CcSEcCtD
Almotriptan—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00115	CcSEcCtD
Almotriptan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000168	0.00115	CcSEcCtD
Almotriptan—Tachycardia—Lisinopril—systemic scleroderma	0.000168	0.00114	CcSEcCtD
Almotriptan—Abdominal pain—Azathioprine—systemic scleroderma	0.000167	0.00114	CcSEcCtD
Almotriptan—Body temperature increased—Azathioprine—systemic scleroderma	0.000167	0.00114	CcSEcCtD
Almotriptan—Skin disorder—Lisinopril—systemic scleroderma	0.000167	0.00114	CcSEcCtD
Almotriptan—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00114	CcSEcCtD
Almotriptan—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000166	0.00113	CcSEcCtD
Almotriptan—Diarrhoea—Captopril—systemic scleroderma	0.000166	0.00113	CcSEcCtD
Almotriptan—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00113	CcSEcCtD
Almotriptan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00113	CcSEcCtD
Almotriptan—Feeling abnormal—Leflunomide—systemic scleroderma	0.000165	0.00113	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000165	0.00112	CcSEcCtD
Almotriptan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000164	0.00112	CcSEcCtD
Almotriptan—Nausea—Mometasone—systemic scleroderma	0.000164	0.00112	CcSEcCtD
Almotriptan—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000164	0.00112	CcSEcCtD
Almotriptan—Pain—Mycophenolic acid—systemic scleroderma	0.000163	0.00111	CcSEcCtD
Almotriptan—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00111	CcSEcCtD
Almotriptan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00111	CcSEcCtD
Almotriptan—Hyperglycaemia—Prednisone—systemic scleroderma	0.000162	0.00111	CcSEcCtD
Almotriptan—Dizziness—Captopril—systemic scleroderma	0.00016	0.0011	CcSEcCtD
Almotriptan—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00016	0.00109	CcSEcCtD
Almotriptan—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00109	CcSEcCtD
Almotriptan—Abdominal pain—Leflunomide—systemic scleroderma	0.000158	0.00108	CcSEcCtD
Almotriptan—Body temperature increased—Leflunomide—systemic scleroderma	0.000158	0.00108	CcSEcCtD
Almotriptan—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000158	0.00108	CcSEcCtD
Almotriptan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Myocardial infarction—Prednisone—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Breast disorder—Methotrexate—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000157	0.00107	CcSEcCtD
Almotriptan—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00107	CcSEcCtD
Almotriptan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000156	0.00107	CcSEcCtD
Almotriptan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000156	0.00107	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00106	CcSEcCtD
Almotriptan—Insomnia—Lisinopril—systemic scleroderma	0.000155	0.00106	CcSEcCtD
Almotriptan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00106	CcSEcCtD
Almotriptan—Paraesthesia—Lisinopril—systemic scleroderma	0.000154	0.00105	CcSEcCtD
Almotriptan—Vomiting—Captopril—systemic scleroderma	0.000154	0.00105	CcSEcCtD
Almotriptan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00105	CcSEcCtD
Almotriptan—Dyspnoea—Lisinopril—systemic scleroderma	0.000153	0.00105	CcSEcCtD
Almotriptan—Rash—Captopril—systemic scleroderma	0.000153	0.00104	CcSEcCtD
Almotriptan—Dermatitis—Captopril—systemic scleroderma	0.000153	0.00104	CcSEcCtD
Almotriptan—Somnolence—Lisinopril—systemic scleroderma	0.000153	0.00104	CcSEcCtD
Almotriptan—Headache—Captopril—systemic scleroderma	0.000152	0.00104	CcSEcCtD
Almotriptan—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00104	CcSEcCtD
Almotriptan—Dyspepsia—Lisinopril—systemic scleroderma	0.000151	0.00103	CcSEcCtD
Almotriptan—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000151	0.00103	CcSEcCtD
Almotriptan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000151	0.00103	CcSEcCtD
Almotriptan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00103	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000148	0.00101	CcSEcCtD
Almotriptan—Fatigue—Lisinopril—systemic scleroderma	0.000148	0.00101	CcSEcCtD
Almotriptan—Shock—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00101	CcSEcCtD
Almotriptan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00101	CcSEcCtD
Almotriptan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000147	0.00101	CcSEcCtD
Almotriptan—Pain—Lisinopril—systemic scleroderma	0.000147	0.001	CcSEcCtD
Almotriptan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.001	CcSEcCtD
Almotriptan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000998	CcSEcCtD
Almotriptan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000994	CcSEcCtD
Almotriptan—Diarrhoea—Azathioprine—systemic scleroderma	0.000145	0.000989	CcSEcCtD
Almotriptan—Nausea—Captopril—systemic scleroderma	0.000144	0.000984	CcSEcCtD
Almotriptan—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000144	0.000982	CcSEcCtD
Almotriptan—Asthenia—Leflunomide—systemic scleroderma	0.000143	0.00098	CcSEcCtD
Almotriptan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000142	0.000967	CcSEcCtD
Almotriptan—Pruritus—Leflunomide—systemic scleroderma	0.000141	0.000966	CcSEcCtD
Almotriptan—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00014	0.000959	CcSEcCtD
Almotriptan—Dizziness—Azathioprine—systemic scleroderma	0.00014	0.000956	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000936	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000137	0.000935	CcSEcCtD
Almotriptan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000137	0.000934	CcSEcCtD
Almotriptan—Diarrhoea—Leflunomide—systemic scleroderma	0.000137	0.000934	CcSEcCtD
Almotriptan—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00093	CcSEcCtD
Almotriptan—Body temperature increased—Lisinopril—systemic scleroderma	0.000136	0.000927	CcSEcCtD
Almotriptan—Abdominal pain—Lisinopril—systemic scleroderma	0.000136	0.000927	CcSEcCtD
Almotriptan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000923	CcSEcCtD
Almotriptan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000135	0.000921	CcSEcCtD
Almotriptan—Vomiting—Azathioprine—systemic scleroderma	0.000135	0.000919	CcSEcCtD
Almotriptan—Eye disorder—Prednisone—systemic scleroderma	0.000134	0.000916	CcSEcCtD
Almotriptan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000916	CcSEcCtD
Almotriptan—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000914	CcSEcCtD
Almotriptan—Rash—Azathioprine—systemic scleroderma	0.000134	0.000912	CcSEcCtD
Almotriptan—Dermatitis—Azathioprine—systemic scleroderma	0.000133	0.000911	CcSEcCtD
Almotriptan—Headache—Azathioprine—systemic scleroderma	0.000133	0.000906	CcSEcCtD
Almotriptan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000905	CcSEcCtD
Almotriptan—Dizziness—Leflunomide—systemic scleroderma	0.000132	0.000903	CcSEcCtD
Almotriptan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000131	0.000891	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—systemic scleroderma	0.00013	0.000887	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000887	CcSEcCtD
Almotriptan—Immune system disorder—Prednisone—systemic scleroderma	0.00013	0.000886	CcSEcCtD
Almotriptan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000879	CcSEcCtD
Almotriptan—Vomiting—Leflunomide—systemic scleroderma	0.000127	0.000868	CcSEcCtD
Almotriptan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000127	0.000864	CcSEcCtD
Almotriptan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000126	0.000861	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—systemic scleroderma	0.000126	0.000861	CcSEcCtD
Almotriptan—Rash—Leflunomide—systemic scleroderma	0.000126	0.000861	CcSEcCtD
Almotriptan—Dermatitis—Leflunomide—systemic scleroderma	0.000126	0.00086	CcSEcCtD
Almotriptan—Mental disorder—Prednisone—systemic scleroderma	0.000126	0.000859	CcSEcCtD
Almotriptan—Nausea—Azathioprine—systemic scleroderma	0.000126	0.000859	CcSEcCtD
Almotriptan—Headache—Leflunomide—systemic scleroderma	0.000125	0.000855	CcSEcCtD
Almotriptan—Erythema—Prednisone—systemic scleroderma	0.000125	0.000854	CcSEcCtD
Almotriptan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000847	CcSEcCtD
Almotriptan—Asthenia—Lisinopril—systemic scleroderma	0.000123	0.000842	CcSEcCtD
Almotriptan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00084	CcSEcCtD
Almotriptan—Pruritus—Lisinopril—systemic scleroderma	0.000122	0.00083	CcSEcCtD
Almotriptan—Vomiting—Mycophenolic acid—systemic scleroderma	0.000121	0.000828	CcSEcCtD
Almotriptan—Rash—Mycophenolic acid—systemic scleroderma	0.00012	0.000821	CcSEcCtD
Almotriptan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00012	0.00082	CcSEcCtD
Almotriptan—Headache—Mycophenolic acid—systemic scleroderma	0.00012	0.000816	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—systemic scleroderma	0.000119	0.000813	CcSEcCtD
Almotriptan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000813	CcSEcCtD
Almotriptan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000813	CcSEcCtD
Almotriptan—Nausea—Leflunomide—systemic scleroderma	0.000119	0.000811	CcSEcCtD
Almotriptan—Vision blurred—Prednisone—systemic scleroderma	0.000118	0.000805	CcSEcCtD
Almotriptan—Diarrhoea—Lisinopril—systemic scleroderma	0.000118	0.000803	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—systemic scleroderma	0.000116	0.000792	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—systemic scleroderma	0.000116	0.00079	CcSEcCtD
Almotriptan—Agitation—Prednisone—systemic scleroderma	0.000115	0.000785	CcSEcCtD
Almotriptan—Angioedema—Prednisone—systemic scleroderma	0.000114	0.00078	CcSEcCtD
Almotriptan—Dizziness—Lisinopril—systemic scleroderma	0.000114	0.000776	CcSEcCtD
Almotriptan—Nausea—Mycophenolic acid—systemic scleroderma	0.000113	0.000774	CcSEcCtD
Almotriptan—Malaise—Prednisone—systemic scleroderma	0.000113	0.00077	CcSEcCtD
Almotriptan—Vertigo—Prednisone—systemic scleroderma	0.000112	0.000767	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—systemic scleroderma	0.000112	0.000766	CcSEcCtD
Almotriptan—Syncope—Prednisone—systemic scleroderma	0.000112	0.000766	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—systemic scleroderma	0.000112	0.000764	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—systemic scleroderma	0.000111	0.000761	CcSEcCtD
Almotriptan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000757	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—systemic scleroderma	0.00011	0.00075	CcSEcCtD
Almotriptan—Vomiting—Lisinopril—systemic scleroderma	0.000109	0.000746	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—systemic scleroderma	0.000108	0.00074	CcSEcCtD
Almotriptan—Rash—Lisinopril—systemic scleroderma	0.000108	0.00074	CcSEcCtD
Almotriptan—Convulsion—Prednisone—systemic scleroderma	0.000108	0.00074	CcSEcCtD
Almotriptan—Dermatitis—Lisinopril—systemic scleroderma	0.000108	0.000739	CcSEcCtD
Almotriptan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000737	CcSEcCtD
Almotriptan—Hypertension—Prednisone—systemic scleroderma	0.000108	0.000737	CcSEcCtD
Almotriptan—Chills—Methotrexate—systemic scleroderma	0.000108	0.000735	CcSEcCtD
Almotriptan—Headache—Lisinopril—systemic scleroderma	0.000108	0.000735	CcSEcCtD
Almotriptan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000727	CcSEcCtD
Almotriptan—Myalgia—Prednisone—systemic scleroderma	0.000106	0.000727	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—systemic scleroderma	0.000106	0.000727	CcSEcCtD
Almotriptan—Anxiety—Prednisone—systemic scleroderma	0.000106	0.000724	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000106	0.000722	CcSEcCtD
Almotriptan—Discomfort—Prednisone—systemic scleroderma	0.000105	0.000718	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—systemic scleroderma	0.000105	0.000718	CcSEcCtD
Almotriptan—Erythema—Methotrexate—systemic scleroderma	0.000104	0.000713	CcSEcCtD
Almotriptan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000703	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—systemic scleroderma	0.000102	0.000699	CcSEcCtD
Almotriptan—Nausea—Lisinopril—systemic scleroderma	0.000102	0.000697	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000102	0.000697	CcSEcCtD
Almotriptan—Back pain—Methotrexate—systemic scleroderma	0.000101	0.00069	CcSEcCtD
Almotriptan—Shock—Prednisone—systemic scleroderma	0.0001	0.000685	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—systemic scleroderma	0.0001	0.000683	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—systemic scleroderma	9.96e-05	0.00068	CcSEcCtD
Almotriptan—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.95e-05	0.00068	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—systemic scleroderma	9.91e-05	0.000677	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—systemic scleroderma	9.86e-05	0.000674	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—systemic scleroderma	9.85e-05	0.000672	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—systemic scleroderma	9.7e-05	0.000662	CcSEcCtD
Almotriptan—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.57e-05	0.000654	CcSEcCtD
Almotriptan—Rash—Mycophenolate mofetil—systemic scleroderma	9.49e-05	0.000648	CcSEcCtD
Almotriptan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.48e-05	0.000647	CcSEcCtD
Almotriptan—Headache—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000644	CcSEcCtD
Almotriptan—Malaise—Methotrexate—systemic scleroderma	9.42e-05	0.000643	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—systemic scleroderma	9.39e-05	0.000641	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.3e-05	0.000635	CcSEcCtD
Almotriptan—Insomnia—Prednisone—systemic scleroderma	9.23e-05	0.00063	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—systemic scleroderma	9.16e-05	0.000626	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—systemic scleroderma	9.05e-05	0.000618	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—systemic scleroderma	8.98e-05	0.000613	CcSEcCtD
Almotriptan—Nausea—Mycophenolate mofetil—systemic scleroderma	8.94e-05	0.000611	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—systemic scleroderma	8.9e-05	0.000607	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—systemic scleroderma	8.9e-05	0.000607	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—systemic scleroderma	8.9e-05	0.000607	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.83e-05	0.000603	CcSEcCtD
Almotriptan—Fatigue—Prednisone—systemic scleroderma	8.8e-05	0.000601	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—systemic scleroderma	8.79e-05	0.0006	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—systemic scleroderma	8.6e-05	0.000587	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—systemic scleroderma	8.53e-05	0.000582	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—systemic scleroderma	8.41e-05	0.000574	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—systemic scleroderma	8.36e-05	0.000571	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—systemic scleroderma	8.34e-05	0.00057	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—systemic scleroderma	8.28e-05	0.000566	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—systemic scleroderma	8.24e-05	0.000563	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—systemic scleroderma	8.07e-05	0.000551	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—systemic scleroderma	8.07e-05	0.000551	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.77e-05	0.000531	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—systemic scleroderma	7.71e-05	0.000527	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—systemic scleroderma	7.66e-05	0.000523	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—systemic scleroderma	7.6e-05	0.000519	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—systemic scleroderma	7.58e-05	0.000518	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—systemic scleroderma	7.52e-05	0.000513	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—systemic scleroderma	7.51e-05	0.000513	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.36e-05	0.000503	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—systemic scleroderma	7.35e-05	0.000502	CcSEcCtD
Almotriptan—Asthenia—Prednisone—systemic scleroderma	7.32e-05	0.0005	CcSEcCtD
Almotriptan—Pain—Methotrexate—systemic scleroderma	7.29e-05	0.000498	CcSEcCtD
Almotriptan—Pruritus—Prednisone—systemic scleroderma	7.22e-05	0.000493	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—systemic scleroderma	7.03e-05	0.00048	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—systemic scleroderma	6.98e-05	0.000477	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.97e-05	0.000476	CcSEcCtD
Almotriptan—Dizziness—Prednisone—systemic scleroderma	6.75e-05	0.000461	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—systemic scleroderma	6.74e-05	0.00046	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—systemic scleroderma	6.74e-05	0.00046	CcSEcCtD
Almotriptan—Vomiting—Prednisone—systemic scleroderma	6.49e-05	0.000443	CcSEcCtD
Almotriptan—Rash—Prednisone—systemic scleroderma	6.43e-05	0.000439	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—systemic scleroderma	6.43e-05	0.000439	CcSEcCtD
Almotriptan—Headache—Prednisone—systemic scleroderma	6.39e-05	0.000436	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—systemic scleroderma	6.28e-05	0.000429	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—systemic scleroderma	6.12e-05	0.000418	CcSEcCtD
Almotriptan—Nausea—Prednisone—systemic scleroderma	6.06e-05	0.000414	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—systemic scleroderma	6.03e-05	0.000412	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—systemic scleroderma	5.83e-05	0.000398	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—systemic scleroderma	5.64e-05	0.000385	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—systemic scleroderma	5.42e-05	0.00037	CcSEcCtD
Almotriptan—Rash—Methotrexate—systemic scleroderma	5.38e-05	0.000367	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—systemic scleroderma	5.37e-05	0.000367	CcSEcCtD
Almotriptan—Headache—Methotrexate—systemic scleroderma	5.34e-05	0.000365	CcSEcCtD
Almotriptan—Nausea—Methotrexate—systemic scleroderma	5.07e-05	0.000346	CcSEcCtD
Almotriptan—HTR1B—artery—systemic scleroderma	2.7e-05	0.156	CbGeAlD
Almotriptan—HTR1D—artery—systemic scleroderma	2.61e-05	0.151	CbGeAlD
Almotriptan—HTR1B—blood vessel—systemic scleroderma	2.1e-05	0.121	CbGeAlD
Almotriptan—HTR1D—blood vessel—systemic scleroderma	2.03e-05	0.117	CbGeAlD
Almotriptan—FMO3—lung—systemic scleroderma	1.11e-05	0.0639	CbGeAlD
Almotriptan—HTR1D—connective tissue—systemic scleroderma	1.04e-05	0.0602	CbGeAlD
Almotriptan—MAOA—connective tissue—systemic scleroderma	7.94e-06	0.0458	CbGeAlD
Almotriptan—CYP2C19—digestive system—systemic scleroderma	5.86e-06	0.0338	CbGeAlD
Almotriptan—MAOA—digestive system—systemic scleroderma	5.74e-06	0.0331	CbGeAlD
Almotriptan—MAOA—tendon—systemic scleroderma	5.46e-06	0.0315	CbGeAlD
Almotriptan—MAOA—lung—systemic scleroderma	4.79e-06	0.0276	CbGeAlD
Almotriptan—CYP1A2—digestive system—systemic scleroderma	4.79e-06	0.0276	CbGeAlD
Almotriptan—CYP2E1—digestive system—systemic scleroderma	4.31e-06	0.0248	CbGeAlD
Almotriptan—CYP2E1—tendon—systemic scleroderma	4.1e-06	0.0236	CbGeAlD
Almotriptan—CYP1A2—lung—systemic scleroderma	4e-06	0.0231	CbGeAlD
Almotriptan—CYP2E1—lung—systemic scleroderma	3.6e-06	0.0207	CbGeAlD
Almotriptan—CYP3A4—digestive system—systemic scleroderma	3.47e-06	0.02	CbGeAlD
Almotriptan—CYP2D6—digestive system—systemic scleroderma	3.41e-06	0.0197	CbGeAlD
